Dopamine and addiction: what have we learned from 40 years of research

M Solinas, P Belujon, PO Fernagut, M Jaber… - Journal of Neural …, 2019 - Springer
Among the neurotransmitters involved in addiction, dopamine (DA) is clearly the best known.
The critical role of DA in addiction is supported by converging evidence that has been …

Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease

CL German, MG Baladi, LM McFadden… - Pharmacological …, 2015 - Elsevier
Dopamine (DA) plays a well recognized role in a variety of physiologic functions such as
movement, cognition, mood, and reward. Consequently, many human disorders are due, in …

Neurotransmitter and psychostimulant recognition by the dopamine transporter

KH Wang, A Penmatsa, E Gouaux - Nature, 2015 - nature.com
Abstract Na+/Cl–-coupled biogenic amine transporters are the primary targets of therapeutic
and abused drugs, ranging from antidepressants to the psychostimulants cocaine and …

Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors

GE DiCarlo, JI Aguilar, HJG Matthies… - The Journal of …, 2020 - Am Soc Clin Investig
The precise regulation of synaptic dopamine (DA) content by the DA transporter (DAT)
ensures the phasic nature of the DA signal, which underlies the ability of DA to encode …

Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons

F Mermer, S Poliquin, K Rigsby, A Rastogi, W Shen… - Brain, 2021 - academic.oup.com
Solute carrier family 6 member 1 (SLC6A1) is abundantly expressed in the develo** brain
even before the CNS is formed. Its encoded GABA transporter 1 (GAT-1) is responsible for …

Dopaminergic dysregulation in syndromic autism spectrum disorders: insights from genetic mouse models

P Kosillo, HS Bateup - Frontiers in Neural Circuits, 2021 - frontiersin.org
Autism spectrum disorder (ASD) is a neurodevelopmental disorder defined by altered social
interaction and communication, and repetitive, restricted, inflexible behaviors. Approximately …

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease

KM Lohr, ST Masoud, A Salahpour… - European Journal of …, 2017 - Wiley Online Library
Dopamine was first identified as a neurotransmitter localized to the midbrain over 50 years
ago. The dopamine transporter (DAT; SLC 6A3) and the vesicular monoamine transporter 2 …

[HTML][HTML] The human channel gating–modifying A749G CACNA1D (Cav1. 3) variant induces a neurodevelopmental syndrome–like phenotype in mice

NJ Ortner, A Sah, E Paradiso, J Shin, S Stojanovic… - JCI insight, 2023 - ncbi.nlm.nih.gov
Germline de novo missense variants of the CACNA1D gene, encoding the pore-forming α1
subunit of Cav1. 3 L-type Ca 2+ channels (LTCCs), have been found in patients with …

Serotonin-releasing agents with reduced off-target effects

FP Mayer, M Niello, D Cintulova, S Sideromenos… - Molecular …, 2023 - nature.com
Increasing extracellular levels of serotonin (5-HT) in the brain ameliorates symptoms of
depression and anxiety-related disorders, eg, social phobias and post-traumatic stress …

[HTML][HTML] Functional and biochemical consequences of disease variants in neurotransmitter transporters: a special emphasis on folding and trafficking deficits

S Bhat, A El-Kasaby, M Freissmuth, S Sucic - Pharmacology & therapeutics, 2021 - Elsevier
Neurotransmitters, such as γ-aminobutyric acid, glutamate, acetyl choline, glycine and the
monoamines, facilitate the crosstalk within the central nervous system. The designated …